semaglutide and mounjaro GLP-1 vs Ozempic vs Wegovy vs Mounjaro vs Ozempic - NowPatient

glucagon suppression, lowering hepatic glucose output Central Nervous System: Decreases food intake by targeting homeostatic and hedonic appetite pathways (hindbrain/hypothalamus), reducing hunger and cravings, and enhancing satiety Gastrointestinal Tract: Delays gastric emptying, contributing to satiety (transient effect at higher doses) Adiposity/Energy Intake : Weight loss is primarily driven by sustained reduction in caloric intake, not increased energy expenditure Biological Activity Potent GLP-1 receptor agonist Enhances insulin secretion (glucose-dependent) Suppresses glucagon secretion Reduces appetite and caloric intake Produces significant, sustained body weight loss Improves cardiometabolic risk factors (glycemia, blood pressure, lipids) Storage Refrigerate once reconstituted

Nutrition-related side effects: Nausea and constipation change how people eat during dose changes

Give us a call today to find out how we can help.

10.1111/j.1432-1033.1994.00617.x 35

GLP-1 receptor agonists like semaglutide work by slowing the rate at which food moves from your stomach into your small intestinea process called gastric emptying